1 |
10% metronidazole ointment |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
096 [1] 96 💬 |
2 |
11c-flumazenil |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
206 [1] 206 💬 |
3 |
1500mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
4 |
18f-ro6958948 |
- |
- |
- |
- |
005 [3] 5 , 7 , 127 💬 |
5 |
250mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
6 |
500mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
7 |
750mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
8 |
[11c]flumazenil |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 [1] 13 💬 |
9 |
[18f]flumazenil |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
206 [1] 206 💬 |
10 |
Act-050089 (ro 61-0612) |
- |
- |
- |
- |
086 [1] 86 💬 |
11 |
Amoxicillin, metronidazole and tetracycline |
Amoxicillin |
[7] D00201 D00201, D00229 D00229, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
097 [1] 97 💬 |
12 |
Azathioprine or mesalazine |
Azathioprine |
[3] D00238 D00238, D00377 D00377, D03033 D03033 💬 |
- |
- |
096 [1] 96 💬 |
13 |
Azithromycin + metronidazole |
Azithromycin |
[6] D00409 D00409, D02134 D02134, D05016 D05016, D05017 D05017, D06390 D06390, D07486 D07486 💬 |
- |
- |
096 [1] 96 💬 |
14 |
Behavioral: role of dopamine |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
15 |
Benznidazole |
Benznidazole |
[1] D02489 D02489 💬 |
- |
- |
065 [1] 65 💬 |
16 |
Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) |
Digoxin |
[13] D00298 D00298, D00330 D00330, D00455 D00455, D00529 D00529, D00550 D00550, D00696 D00696, D01207 D01207, D01475 D01475, D02290 D02290, D05028 D05028, D05259 D05259, D05261 D05261, D08229 D08229 💬 |
ATP1A1 [25] ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 |
Adrenergic signaling in cardiomyocytes [49] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
17 |
Bms-986089-01 (ro7239361) , anti-myostatin |
- |
- |
- |
- |
113 [1] 113 💬 |
18 |
Bms-986089-01 (ro7239361) injections, 15 mg/syringe (21.4 mg/ml) |
- |
- |
- |
- |
113 [1] 113 💬 |
19 |
Bms-986089-01 (ro7239361) injections, 35 mg/syringe (50 mg/ml) |
- |
- |
- |
- |
113 [1] 113 💬 |
20 |
Bms-986089-01 (ro7239361) injections, 50 mg/syringe (71.4 mg/ml) |
- |
- |
- |
- |
113 [1] 113 💬 |
21 |
Bms-986089-01 (ro7239361) injections, 7.5 mg/syringe (10.7 mg/ml) |
- |
- |
- |
- |
113 [1] 113 💬 |
22 |
Bms-986089-01 (ro7239361), anti-myostatin |
- |
- |
- |
- |
113 [1] 113 💬 |
23 |
Butyrate enemas + routine management |
Butyric Acid |
[1] D05866 D05866 💬 |
- |
- |
291 [1] 291 💬 |
24 |
C5 inh mab, sky59, ro/ch7092230 |
- |
- |
- |
- |
062 [1] 62 💬 |
25 |
Calcitriol |
Calcitriol |
[1] D00129 D00129 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
037 [8] 37, 46, 49, 66, 96, 158, 235, 326 💬 |
26 |
Calcitriol & calcium |
Calcitriol |
[1] D00129 D00129 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
27 |
Calcium rosuvastatin |
Calcium |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 [1] 79 💬 |
28 |
Ceftriaxone |
Ceftriaxone |
[2] D00924 D00924, D07659 D07659 💬 |
- |
- |
002 [3] 2 , 6 , 97 💬 |
29 |
Crestor tablets (calcium rosuvastatin) film-coated tablets |
Calcium |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 [1] 79 💬 |
30 |
Delayed and extended release mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
31 |
Delayed release 6mp or calcitriol vs. purinethol |
Calcitriol |
[1] D00129 D00129 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
32 |
Dexmedetomidine with ropivacaine |
Dexmedetomidine |
[4] D00514 D00514, D01205 D01205, D04048 D04048, D08490 D08490 💬 |
ADRA2A [8] ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [5] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway |
070 [1] 70 💬 |
33 |
Diagnostic test: [18f]-ro6958948 |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
34 |
Diagnostic test: elecsys (roche) abeta42, ttau and ptau |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
35 |
Diagnostic test: pet with [11c]flumazenil |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 [1] 13 💬 |
36 |
Diagnostic test: rey-osterrieth complex figure test (rocft) |
- |
- |
- |
- |
006 [1] 6 💬 |
37 |
Diagnostic test: rotational thromboelastometry |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
38 |
Dopamine agonists (pramipexole, ropirinole) |
Dopamine |
[4] D00559 D00559, D00633 D00633, D05575 D05575, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
39 |
Emicizumab (ace910, ro5534262) |
Emicizumab |
[1] D10821 D10821 💬 |
F10 [2] F10, F9 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
288 [1] 288 💬 |
40 |
Eu-approved roactemra |
- |
- |
- |
- |
046 [1] 46 💬 |
41 |
Flumazenil |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [5] 6 , 13, 17, 18, 206 💬 |
42 |
Flurbiprofen |
Flurbiprofen |
[3] D00330 D00330, D01475 D01475, D02290 D02290 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [3] 13, 21, 46 💬 |
43 |
Gamma-secretase/notch signalling pathway inhibitor ro4929097 |
- |
- |
- |
- |
074 [1] 74 💬 |
44 |
Gdc-0853 ro7010939 |
- |
- |
- |
- |
013 [3] 13, 46, 49 💬 |
45 |
Glycyrrhiza glabra root |
Glycyrrhiza glabra |
- |
- |
- |
097 [1] 97 💬 |
46 |
Herbal medicinal mixture (roucongrong, heshouwu etc.) |
Reynoutria multiflora root |
- |
- |
- |
006 [1] 6 💬 |
47 |
Hp-3000 (ropinirole hydrochloride patch) |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
48 |
Hp-3000(ropinirole hydrochloride patch) |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
49 |
Humira 40 mg injekcní roztok v predplnené injekcní stríkacce |
- |
- |
- |
- |
096 [1] 96 💬 |
50 |
Hydrocortisone roussel |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
083 [1] 83 💬 |
51 |
Idec-c2b8, ro 45-2294 |
- |
- |
- |
- |
064 [1] 64 💬 |
52 |
Liberase enzyme (roche) |
- |
- |
- |
- |
085 [2] 85, 229 💬 |
53 |
Ly03003 ( rotigotine, extended-release microspheres) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
54 |
Ly03003 (rotigotine extended release microspheres for intramuscular [im] injection) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
55 |
Ly03003( the name of rotigotine) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
56 |
Ly03003(rotigotine,extended-release microspheres) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
57 |
Magnesium with ropivacaine |
Magnesium |
[2] D04048 D04048, D08490 D08490 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
070 [1] 70 💬 |
58 |
Mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
046 [3] 46, 96, 97 💬 |
59 |
Mesalazine (3,600 mg) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
60 |
Mesalazine (asacol®) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
61 |
Mesalazine (mesalamine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
62 |
Mesalazine - tid 1000 mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
63 |
Mesalazine - tid 2x 500 mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
64 |
Mesalazine 1000 mg gastro-resistant tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
65 |
Mesalazine 250mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
66 |
Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet |
Mesalazine |
[2] D00377 D00377, D02486 D02486 💬 |
- |
- |
097 [1] 97 💬 |
67 |
Mesalazine 4g enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
68 |
Mesalazine 500 mg gastro-resistant tablets (salofa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
69 |
Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
70 |
Mesalazine ec 500 mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
71 |
Mesalazine enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
72 |
Mesalazine liquid enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
73 |
Mesalazine slow-release granules |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
74 |
Mesalazine sustained-release tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
75 |
Mesalazine tablet |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
76 |
Mesalazine tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
77 |
Mesalazine with hydrocortisone sodium succinate |
Hydrocortisone |
[2] D00088 D00088, D00377 D00377 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
78 |
Mesalazine, tripterygium glycosides |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
79 |
Metronidazole |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 [8] 46, 51, 63, 94, 95, 96, 97, 291 💬 |
80 |
Metronidazole capsule 50 mg |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
097 [1] 97 💬 |
81 |
Minoxidil |
Minoxidil |
[1] D00418 D00418 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
179 [1] 179 💬 |
82 |
Mmx mesalamine/ mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
83 |
Mmx mesalamine/mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
84 |
Mmx mesalamine/mesalazine (high dose) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
85 |
Mmx mesalamine/mesalazine (low dose) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
86 |
Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142 |
BMS-986142 |
[11] D00298 D00298, D00330 D00330, D00529 D00529, D00550 D00550, D00696 D00696, D00893 D00893, D01475 D01475, D02290 D02290, D05028 D05028, D08229 D08229, D08410 D08410 💬 |
ATP1A1 [24] ATP1A1, ATP1A2, ATP1A3, ATP1A4, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HMGCR, PTGS1, PTGS2 💬 |
AMPK signaling pathway [49] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Terpenoid backbone biosynthesis, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
87 |
Oral roflumilast |
Roflumilast |
[1] D05744 D05744 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
299 [1] 299 💬 |
88 |
Other: empiric use of calcium carbonate and calcitriol |
Calcitriol |
[3] D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
89 |
Other: mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
90 |
Other: pth based calcium carbonate and calcitriol repletion |
Calcitriol |
[3] D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
91 |
Other: rosemary essential oil |
Rosemary |
- |
- |
- |
051 [1] 51 💬 |
92 |
Other: rotigotine |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
93 |
Other: routine |
- |
- |
- |
- |
240 [1] 240 💬 |
94 |
Other: routine management |
- |
- |
- |
- |
291 [1] 291 💬 |
95 |
Other: routine therapy |
- |
- |
- |
- |
299 [1] 299 💬 |
96 |
Other: transthoracic echocardiography at rest, during plr, hg and cpx (including blood gas analysis in both groups). additionally fallot patients will undergo routine blood testings. |
- |
- |
- |
- |
215 [1] 215 💬 |
97 |
Overencapsulated mesalazine tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
98 |
Pet with 11c-flumazenil |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 [1] 13 💬 |
99 |
Pramipexole or ropinirole |
Pramipexole |
[4] D00559 D00559, D00784 D00784, D05575 D05575, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
100 |
Pro145223 (ro5490261) |
- |
- |
- |
- |
097 [1] 97 💬 |
101 |
Procedure: routine drainage surgery |
- |
- |
- |
- |
096 [1] 96 💬 |
102 |
Pzn 8881655(rochepharma ag) |
- |
- |
- |
- |
085 [1] 85 💬 |
103 |
R-roscovitine |
Seliciclib |
- |
- |
- |
075 [1] 75 💬 |
104 |
Rad001 round tablets |
- |
- |
- |
- |
158 [1] 158 💬 |
105 |
Ramelteon |
Ramelteon |
[1] D02689 D02689 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
006 [3] 6 , 8 , 46 💬 |
106 |
Rapamycin-calcitriol combination |
Calcitriol |
[2] D00129 D00129, D00753 D00753 💬 |
MTOR [2] MTOR, VDR 💬 |
AMPK signaling pathway [54] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Mineral absorption, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Tuberculosis, Type II diabetes mellitus, mTOR signaling pathway |
158 [1] 158 💬 |
107 |
Recombinant human growth hormone + rosiglitazone |
Rosiglitazone |
[3] D00596 D00596, D02691 D02691, D08491 D08491 💬 |
GHR [2] GHR, PPARG 💬 |
AMPK signaling pathway [14] AMPK signaling pathway, Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Huntington disease, JAK-STAT signaling pathway, Longevity regulating pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
265 [1] 265 💬 |
108 |
Riluzole oral soluble film (rosf) 50 mg |
Riluzole |
[1] D00775 D00775 💬 |
GRIA1 [14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [23] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 [1] 2 💬 |
109 |
Ro |
- |
- |
- |
- |
006 [1] 6 💬 |
110 |
Ro 001-9265 |
- |
- |
- |
- |
041 [1] 41 💬 |
111 |
Ro 001-9265/f02 |
- |
- |
- |
- |
041 [1] 41 💬 |
112 |
Ro 001-9265/f02-01 |
- |
- |
- |
- |
046 [1] 46 💬 |
113 |
Ro 001-9265/f03 |
- |
- |
- |
- |
041 [1] 41 💬 |
114 |
Ro 001-9265/f04 |
- |
- |
- |
- |
041 [1] 41 💬 |
115 |
Ro 002-9893/f02 |
- |
- |
- |
- |
046 [1] 46 💬 |
116 |
Ro 106-1443 |
- |
- |
- |
- |
049 [1] 49 💬 |
117 |
Ro 45-2294 |
- |
- |
- |
- |
046 [1] 46 💬 |
118 |
Ro 47-0203 |
- |
- |
- |
- |
051 [4] 51, 85, 86, 88 💬 |
119 |
Ro 47-0203 / act-050088 |
- |
- |
- |
- |
086 [1] 86 💬 |
120 |
Ro 48-77533 |
- |
- |
- |
- |
046 [1] 46 💬 |
121 |
Ro 487-533/f01 |
- |
- |
- |
- |
271 [1] 271 💬 |
122 |
Ro 487-5733/f01 |
- |
- |
- |
- |
271 [1] 271 💬 |
123 |
Ro 487-7533 |
- |
- |
- |
- |
046 [1] 46 💬 |
124 |
Ro 487-7533/f01 |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
125 |
Ro 487-7533/f10 |
- |
- |
- |
- |
046 [1] 46 💬 |
126 |
Ro 487-7533/f10-02 |
- |
- |
- |
- |
046 [1] 46 💬 |
127 |
Ro 487-7533/f10-04 |
- |
- |
- |
- |
041 [4] 41, 46, 51, 107 💬 |
128 |
Ro 491-7523/f18 |
- |
- |
- |
- |
206 [1] 206 💬 |
129 |
Ro 491-7523/f19 |
- |
- |
- |
- |
206 [1] 206 💬 |
130 |
Ro 496-4913 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
131 |
Ro 496-4913/f03 |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
132 |
Ro 496-4913/f07 |
- |
- |
- |
- |
013 [1] 13 💬 |
133 |
Ro 549-0261/f04 |
- |
- |
- |
- |
097 [1] 97 💬 |
134 |
Ro 549-0261/f04-02 |
- |
- |
- |
- |
096 [1] 96 💬 |
135 |
Ro 549-0261/f08-02 |
- |
- |
- |
- |
096 [1] 96 💬 |
136 |
Ro 551-6922 |
- |
- |
- |
- |
046 [1] 46 💬 |
137 |
Ro 723-4292/f02 |
- |
- |
- |
- |
008 [1] 8 💬 |
138 |
Ro actemra |
- |
- |
- |
- |
046 [1] 46 💬 |
139 |
Ro-47-0203 |
- |
- |
- |
- |
086 [1] 86 💬 |
140 |
Ro-47-0203/029 |
- |
- |
- |
- |
086 [1] 86 💬 |
141 |
Ro-496-4913 |
- |
- |
- |
- |
046 [1] 46 💬 |
142 |
Ro-actemra |
- |
- |
- |
- |
046 [1] 46 💬 |
143 |
Ro001-9265/f04 |
- |
- |
- |
- |
046 [1] 46 💬 |
144 |
Ro0029893 |
- |
- |
- |
- |
046 [1] 46 💬 |
145 |
Ro0220912 |
- |
- |
- |
- |
085 [1] 85 💬 |
146 |
Ro0280296 |
- |
- |
- |
- |
085 [1] 85 💬 |
147 |
Ro045-2294 |
- |
- |
- |
- |
046 [1] 46 💬 |
148 |
Ro0452294/v01 |
- |
- |
- |
- |
043 [2] 43, 44 💬 |
149 |
Ro0452294/v02 |
- |
- |
- |
- |
035 [3] 35, 43, 44 💬 |
150 |
Ro04877533 |
- |
- |
- |
- |
046 [1] 46 💬 |
151 |
Ro04877533/f05/f04 |
- |
- |
- |
- |
046 [1] 46 💬 |
152 |
Ro0506997 |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
153 |
Ro106-1443 |
- |
- |
- |
- |
043 [1] 43 💬 |
154 |
Ro1061443/f02 |
- |
- |
- |
- |
035 [1] 35 💬 |
155 |
Ro3300074 |
- |
- |
- |
- |
231 [1] 231 💬 |
156 |
Ro4402257 |
- |
- |
- |
- |
046 [1] 46 💬 |
157 |
Ro45-2294 |
- |
- |
- |
- |
271 [1] 271 💬 |
158 |
Ro452294/v02 |
- |
- |
- |
- |
046 [1] 46 💬 |
159 |
Ro47-0203 |
- |
- |
- |
- |
086 [1] 86 💬 |
160 |
Ro47-0203 / act-050088 |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
161 |
Ro487-7533 |
- |
- |
- |
- |
046 [1] 46 💬 |
162 |
Ro487-7533/f01-f05 |
- |
- |
- |
- |
046 [1] 46 💬 |
163 |
Ro487-7533/f10-04 |
- |
- |
- |
- |
046 [2] 46, 51 💬 |
164 |
Ro4877533 |
- |
- |
- |
- |
046 [1] 46 💬 |
165 |
Ro4877533 (tcz) |
- |
- |
- |
- |
046 [2] 46, 107 💬 |
166 |
Ro4877533/f01 |
- |
- |
- |
- |
046 [1] 46 💬 |
167 |
Ro4877533/f04-f05 |
- |
- |
- |
- |
046 [1] 46 💬 |
168 |
Ro4917523 |
- |
- |
- |
- |
206 [1] 206 💬 |
169 |
Ro4917523 0.5 mg |
- |
- |
- |
- |
206 [1] 206 💬 |
170 |
Ro4917523 1.5 mg |
- |
- |
- |
- |
206 [1] 206 💬 |
171 |
Ro496-4913 |
- |
- |
- |
- |
046 [1] 46 💬 |
172 |
Ro4964913 |
- |
- |
- |
- |
013 [1] 13 💬 |
173 |
Ro4964913 f07 |
- |
- |
- |
- |
013 [1] 13 💬 |
174 |
Ro4964913/f03 |
- |
- |
- |
- |
013 [1] 13 💬 |
175 |
Ro4964913/f07 |
- |
- |
- |
- |
013 [1] 13 💬 |
176 |
Ro4964913/f07-01 |
- |
- |
- |
- |
013 [1] 13 💬 |
177 |
Ro4964913/f07-01 (commercial) |
- |
- |
- |
- |
013 [1] 13 💬 |
178 |
Ro4964913/f07-01 (development) |
- |
- |
- |
- |
013 [1] 13 💬 |
179 |
Ro5333787 |
- |
- |
- |
- |
013 [1] 13 💬 |
180 |
Ro545-9072/f03 |
- |
- |
- |
- |
053 [1] 53 💬 |
181 |
Ro5459072 |
- |
- |
- |
- |
053 [1] 53 💬 |
182 |
Ro5490255 |
- |
- |
- |
- |
085 [1] 85 💬 |
183 |
Ro5490255/f01-02 |
- |
- |
- |
- |
085 [1] 85 💬 |
184 |
Ro5490261 / f02 |
- |
- |
- |
- |
097 [1] 97 💬 |
185 |
Ro5490261/f02 |
- |
- |
- |
- |
097 [1] 97 💬 |
186 |
Ro5490261/f04-02 |
- |
- |
- |
- |
097 [1] 97 💬 |
187 |
Ro6885247 |
- |
- |
- |
- |
003 [1] 3 💬 |
188 |
Ro6885247/f02 |
- |
- |
- |
- |
003 [1] 3 💬 |
189 |
Ro6885247/f03 |
- |
- |
- |
- |
003 [1] 3 💬 |
190 |
Ro7010939 |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
191 |
Ro7010939/f13 |
- |
- |
- |
- |
049 [1] 49 💬 |
192 |
Ro7034067 |
- |
- |
- |
- |
003 [1] 3 💬 |
193 |
Ro7034067 / f12 |
- |
- |
- |
- |
003 [1] 3 💬 |
194 |
Ro7034067 / f13 |
- |
- |
- |
- |
003 [1] 3 💬 |
195 |
Ro7034067/f06 + solvente (ro |
- |
- |
- |
- |
003 [1] 3 💬 |
196 |
Ro7034067/f06 with solvent (ro7034067/f08) |
- |
- |
- |
- |
003 [1] 3 💬 |
197 |
Ro7034067/f07 + solvente (ro |
- |
- |
- |
- |
003 [1] 3 💬 |
198 |
Ro7034067/f07 with solvent (ro7034067/f09) |
- |
- |
- |
- |
003 [1] 3 💬 |
199 |
Ro7034067/f12 |
- |
- |
- |
- |
003 [1] 3 💬 |
200 |
Ro7034067/f13 |
- |
- |
- |
- |
003 [1] 3 💬 |
201 |
Ro7046015 |
- |
- |
- |
- |
006 [1] 6 💬 |
202 |
Ro7049665 |
- |
- |
- |
- |
097 [1] 97 💬 |
203 |
Ro7090919 |
- |
- |
- |
- |
003 [1] 3 💬 |
204 |
Ro7112689 |
- |
- |
- |
- |
062 [1] 62 💬 |
205 |
Ro7112689/f01 |
- |
- |
- |
- |
062 [1] 62 💬 |
206 |
Ro7112689/f03-01 |
- |
- |
- |
- |
062 [1] 62 💬 |
207 |
Ro7112689/f03-03 |
- |
- |
- |
- |
062 [1] 62 💬 |
208 |
Ro7123520 |
- |
- |
- |
- |
046 [1] 46 💬 |
209 |
Ro7123520/f03-01 |
- |
- |
- |
- |
046 [1] 46 💬 |
210 |
Ro7234292 |
- |
- |
- |
- |
008 [1] 8 💬 |
211 |
Ro7234292 (rg6042) |
- |
- |
- |
- |
008 [1] 8 💬 |
212 |
Ro7239361 |
- |
- |
- |
- |
113 [1] 113 💬 |
213 |
Ro7239361 (bms-986089) |
- |
- |
- |
- |
113 [1] 113 💬 |
214 |
Ro7239361 injections, 15 mg/syringe (21.4 mg/ml) |
- |
- |
- |
- |
113 [1] 113 💬 |
215 |
Ro7239361 injections, 35 mg/syringe (50 mg/ml) |
- |
- |
- |
- |
113 [1] 113 💬 |
216 |
Ro7239361 injections, 50 mg/syringe (71.4 mg/ml) |
- |
- |
- |
- |
113 [1] 113 💬 |
217 |
Ro7239361 injections, 7.5 mg/syringe (10.7 mg/ml) |
- |
- |
- |
- |
113 [1] 113 💬 |
218 |
Ro7246311 |
- |
- |
- |
- |
097 [1] 97 💬 |
219 |
Ro7248824 |
- |
- |
- |
- |
201 [1] 201 💬 |
220 |
Ro7248824/f02-01 |
- |
- |
- |
- |
201 [1] 201 💬 |
221 |
Ro7248824/f03-01 (diluent for ro7248824/f02-01 |
- |
- |
- |
- |
201 [1] 201 💬 |
222 |
Roactemra |
- |
- |
- |
- |
040 [9] 40, 41, 46, 51, 86, 107, 266, 271, 331 💬 |
223 |
Roactemra (r) |
- |
- |
- |
- |
046 [1] 46 💬 |
224 |
Roactemra 162 mg |
- |
- |
- |
- |
046 [2] 46, 51 💬 |
225 |
Roactemra 162 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
041 [1] 41 💬 |
226 |
Roactemra 162 mg solution injectable en seringue préremplie |
- |
- |
- |
- |
046 [1] 46 💬 |
227 |
Roactemra 20 mg/ml concentrado para solución para perfusión |
- |
- |
- |
- |
046 [1] 46 💬 |
228 |
Roactemra 20 mg/ml concentrate for solution for infusion |
- |
- |
- |
- |
046 [1] 46 💬 |
229 |
Roactemra 20 mg/ml concentrate for solution for infusion. |
- |
- |
- |
- |
046 [1] 46 💬 |
230 |
Roactemra 20 mg/ml, concentrado para solución para perfusión |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
231 |
Roactemra 20mg/ml |
- |
- |
- |
- |
040 [1] 40 💬 |
232 |
Roactemra(r) |
- |
- |
- |
- |
046 [1] 46 💬 |
233 |
Roactemra® |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
234 |
Roactemra® 20mg/ml konzentrat |
- |
- |
- |
- |
266 [1] 266 💬 |
235 |
Roactemra®ev product code: prd82321 |
- |
- |
- |
- |
046 [1] 46 💬 |
236 |
Roacterma |
- |
- |
- |
- |
046 [1] 46 💬 |
237 |
Roactmera |
- |
- |
- |
- |
046 [1] 46 💬 |
238 |
Rob 803 |
- |
- |
- |
- |
046 [1] 46 💬 |
239 |
Rob 803 (9-chloro-2,3-dimethyl-6-(n,n-dimethylaminoethylamino-2-oxoethyl)-6h-indolo[2,3-b] quinoxali |
- |
- |
- |
- |
046 [1] 46 💬 |
240 |
Rob 803 (capsules 12.5 mg) |
- |
- |
- |
- |
046 [1] 46 💬 |
241 |
Rob 803 (capsules 15 mg) |
- |
- |
- |
- |
046 [1] 46 💬 |
242 |
Rob 803 (capsules 25 mg) |
- |
- |
- |
- |
046 [1] 46 💬 |
243 |
Rob 803 (capsules 6.25 mg) |
- |
- |
- |
- |
046 [1] 46 💬 |
244 |
Rob 803 12.5mg capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
245 |
Rob 803 15mg capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
246 |
Rob 803 25mg capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
247 |
Rob 803 6.25mg capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
248 |
Rob 803 6.5mg capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
249 |
Rocuronium |
Rocuronium |
[1] D00765 D00765 💬 |
CHRM1 [16] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4 💬 |
Alzheimer disease [15] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
296 [1] 296 💬 |
250 |
Rofecoxib |
Rofecoxib |
[1] D00568 D00568 💬 |
PTGS2 [1] PTGS2 💬 |
Alzheimer disease [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
251 |
Roferon-a |
- |
- |
- |
- |
056 [1] 56 💬 |
252 |
Roferon-a 3miu |
- |
- |
- |
- |
056 [1] 56 💬 |
253 |
Roferon-a, 3miu |
- |
- |
- |
- |
056 [1] 56 💬 |
254 |
Roferon-a, 4.5miu |
- |
- |
- |
- |
056 [1] 56 💬 |
255 |
Roferon-a, 6miu |
- |
- |
- |
- |
056 [1] 56 💬 |
256 |
Roflumilast |
Roflumilast |
[1] D05744 D05744 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
084 [2] 84, 299 💬 |
257 |
Roflumilast oral tablet |
Roflumilast |
[1] D05744 D05744 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
299 [1] 299 💬 |
258 |
Rokan (r) novo 120 mg |
- |
- |
- |
- |
018 [1] 18 💬 |
259 |
Rolipram |
Rolipram |
[1] D01783 D01783 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
008 [2] 8 , 13 💬 |
260 |
Romiplostim |
Romiplostim |
[1] D08990 D08990 💬 |
MPL [1] MPL 💬 |
Cytokine-cytokine receptor interaction [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway |
060 [4] 60, 63, 64, 65 💬 |
261 |
Romiplostin |
- |
- |
- |
- |
063 [1] 63 💬 |
262 |
Romosozumab |
Romosozumab |
[1] D10156 D10156 💬 |
SOST [1] SOST 💬 |
Parathyroid hormone synthesis, secretion and action [2] Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway |
046 [2] 46, 274 💬 |
263 |
Rontalizumab |
Rontalizumab |
[1] D09662 D09662 💬 |
IFNA1 [13] IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 |
Autoimmune thyroid disease [23] Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis |
049 [1] 49 💬 |
264 |
Rop |
- |
- |
- |
- |
006 [1] 6 💬 |
265 |
Rop+l-dopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
266 |
Ropinirole |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [3] 6 , 74, 309 💬 |
267 |
Ropinirole (as hydrochloride) |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
268 |
Ropinirole controlled-release (requip cr) for rls |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
269 |
Ropinirole cr 2mg tablet |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
270 |
Ropinirole cr 8mg tablet |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
271 |
Ropinirole hydrochloride |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [2] 6 , 309 💬 |
272 |
Ropinirole hydrochloride extended-release tablet |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
273 |
Ropinirole hydrochloride extended-release tablet placebo |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
274 |
Ropinirole hydrochloride prolonged release |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
275 |
Ropinirole immediate release |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
276 |
Ropinirole implant |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
277 |
Ropinirole ir |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
278 |
Ropinirole ir tablets |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
279 |
Ropinirole monotherapy |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
280 |
Ropinirole oral product |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
281 |
Ropinirole pr |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
282 |
Ropinirole pr, 2mg |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
283 |
Ropinirole pr/xr |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
284 |
Ropinirole pr/xr tablets |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
285 |
Ropinirole prolonged release |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
286 |
Ropinirole prolonged release/extended release(pr/xr) |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
287 |
Ropinirole xl |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
288 |
Ropinirole xl (formerly cr) |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
289 |
Ropinirole/l-dopa |
Levodopa |
[3] D00059 D00059, D00784 D00784, D08489 D08489 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
290 |
Ropivacaine |
Ropivacaine |
[2] D04048 D04048, D08490 D08490 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
036 [3] 36, 46, 70 💬 |
291 |
Ropivacaine plus normal saline |
Ropivacaine |
[2] D04048 D04048, D08490 D08490 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
070 [1] 70 💬 |
292 |
Roscovitine |
- |
- |
- |
- |
299 [1] 299 💬 |
293 |
Rosemary |
Rosemary |
- |
- |
- |
051 [1] 51 💬 |
294 |
Rosiglitazone |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 [5] 46, 75, 97, 222, 265 💬 |
295 |
Rosiglitazone (avandia) |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
222 [1] 222 💬 |
296 |
Rosiglitazone extended release tablets |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 [1] 46 💬 |
297 |
Rosiglitazone maleate |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 [3] 46, 75, 265 💬 |
298 |
Rosiglitazone xr |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 [1] 46 💬 |
299 |
Rosuvastatin |
Rosuvastatin |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [11] 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
300 |
Rosuvastatin 10 mg |
Rosuvastatin |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
096 [1] 96 💬 |
301 |
Rosuvastatin 20mg |
Rosuvastatin |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 [1] 79 💬 |
302 |
Rosuvastatin calcium |
Calcium |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
049 [4] 49, 79, 97, 299 💬 |
303 |
Rosuvastatin calcium 40mg |
Calcium |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
056 [1] 56 💬 |
304 |
Rosuvastatine eg |
- |
- |
- |
- |
097 [1] 97 💬 |
305 |
Rotigotin |
- |
- |
- |
- |
006 [1] 6 💬 |
306 |
Rotigotina |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
307 |
Rotigotine |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
308 |
Rotigotine (reference product pr 2.1.1) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
309 |
Rotigotine (test product pr 2.3.1) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
310 |
Rotigotine hydrochloride |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
311 |
Rotigotine nasal spray |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
312 |
Rotigotine transdermal patch |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
313 |
Rotigotine transdermal patch 2mg/24h(10cm2) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
314 |
Rotigotine transdermal patch 4mg/24h (20cm2) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
315 |
Rotigotine transdermal patch 6mg/24h (30cm2) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
316 |
Rotigotine transdermal patch 8mg/24h (40cm2) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
317 |
Rotigotine tts (test) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
318 |
Rotigotine, extended-release microspheres |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
319 |
Routine transdermal oestrogen patch |
- |
- |
- |
- |
078 [1] 78 💬 |
320 |
Routine treatment of cd |
- |
- |
- |
- |
096 [1] 96 💬 |
321 |
Roxithromycin |
Roxithromycin |
[1] D01710 D01710 💬 |
- |
- |
046 [2] 46, 299 💬 |
322 |
Royal jelly |
Royal jelly |
[1] D09754 D09754 💬 |
- |
- |
049 [1] 49 💬 |
323 |
Rozanolixizumab |
Rozanolixizumab |
- |
- |
- |
011 [3] 11, 14, 63 💬 |
324 |
Rozerem |
- |
- |
- |
- |
006 [1] 6 💬 |
325 |
Satralizumab (ro5333787/enspryng /sa237) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
326 |
Satralizumab (ro5333787/enspryng/sa237) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
327 |
Satralizumab (ro5333787/sa237) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
328 |
Satrazlizumab (ro5333787/ enspryng /sa237) |
- |
- |
- |
- |
013 [1] 13 💬 |
329 |
Sodium acid pyrophosphate sapp ror 28 food grade |
- |
- |
- |
- |
166 [1] 166 💬 |
330 |
Spd476 (mesalazine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
331 |
Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
332 |
Standardized turmeric root extract |
Turmeric |
- |
- |
- |
299 [1] 299 💬 |
333 |
Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication) |
Amoxicillin |
[7] D00229 D00229, D00276 D00276, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
063 [1] 63 💬 |
334 |
Tocilizumab (actemra or roactemra) |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
335 |
Tocilizumab [roactemra/actemra] |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [4] 46, 51, 107, 331 💬 |
336 |
Tocilizumab [roactemra] |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [1] 46 💬 |
337 |
Tocilizumab infusion roacemtra (eu) |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
266 [1] 266 💬 |
338 |
Tocilizumab roche |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [2] 46, 107 💬 |
339 |
Tolicizumab roche |
- |
- |
- |
- |
046 [1] 46 💬 |
340 |
Traditional chinese medicinal mixture (composed of roucongrong and adjuvant) |
- |
- |
- |
- |
006 [1] 6 💬 |
341 |
Tramadol with ropivacaine |
Ropivacaine |
[4] D01355 D01355, D04048 D04048, D08490 D08490, D08623 D08623 💬 |
OPRM1 [6] OPRM1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [6] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction |
070 [1] 70 💬 |
342 |
Transdermal flumazenil (added 4/2020) |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
343 |
Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere |
- |
- |
- |
- |
013 [1] 13 💬 |
344 |
Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere. |
- |
- |
- |
- |
013 [1] 13 💬 |
345 |
Uttr1147a/ro7021610 (active) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |